These clinical study results are supplied for informational purposes only in the interests of scientific disclosure. They are not intended to substitute for the FDA-approved package insert or other approved labeling. Drug Details Company Name Business Partner Drug Name Generic Name Unique ID Studied Indications or Disease Phase Approved Drug Label Shire Pharmaceuticals Adderall XR Extended release, mixed salts of a single-entity amphetamine SLI381-404 Attention-Deficit/Hyperactivity Disorder Phase IV http://www.adderallxr.com/assets/pdf/prescribing_information.pdf Clinical Study Summary A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR) and Atomoxetine (Strattera) in School-Aged Children With Attention Deficit/Hyperactivity Disorder. S.B. Wigal, J.T. McGough, J.T. McCracken et al. Journal of Attention Disorders,2005;9(1):275-289. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder. J. Biederman, S.B. Wigal, T.J. Spencer et al. Clin Ther,2006;28(2):280-293. http://www.clinicaltrials.gov/ct/screen/BrowseAny?path=%2Fbrowse%2Fby-sponsor%2FINDUSTRY%2FShire%2BPharmaceutical%2BDevelopment&recruiting=false You agree that access to and use of information posted by Shire on the ClinicalStudyResults.org web site is at your own risk. Shire will use reasonable efforts to post up-to-date and accurate information on this web site, but makes no warranty, condition, term, undertaking or representation (express or implied, statutory or otherwise) as to the accuracy, currency, or completeness of such information on this or any related web sites. Shire shall not under any circumstances be liable for any damages, including without limitation, direct, indirect, incidental, consequential or punitive damages, arising from access to, use of, or inability to use information posted by Shire on this web site or related sites, or any errors or omissions in its content. You should rely only on advice from your healthcare professional for your specific situation. Company Study A Randomized, Double-Blind, Parallel-Group Analog Classroom Study, Evaluating ADDERALL XR versus STRATTERA™, Dosed Once-Daily, in Children Aged 6 – 12 With Attention Deficit Hyperactivity Disorder (ADHD) Back to Search Results